// STATE LEGISLATION TRACKER

Colorado SB 164 — Regulation of Lawful Tetrahydrocannabinol Beverages

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Colorado
Bill: SB 164
Session: 2026A
Filed: 2026-04-16
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Colorado SB164 appears to regulate lawful THC beverages, not peptides, prescribing, telehealth, clinician scope, compounding, controlled substances, or prescription monitoring. Based on the title, subjects, and lack of recorded actions, it has no clear impact on peptide users or peptide clinicians.

Key Points

No apparent effect on compounded peptides
No apparent change to off-label prescribing
No apparent change to telehealth peptide care
No apparent change to NP or naturopath scope
No apparent link to 503A or 503B compounding

What to Watch For

Note Watch for posted bill text before assuming there are no health-care licensing provisions.

Note If amendments add pharmacy, prescribing, or controlled-substance language, peptide relevance could change.

Where the Bill Stands

The source lists no recorded actions, so the bill's place in the legislative process cannot be confirmed from the provided information.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws